Position
Chief Commercial Officer
Company
Amylyx Pharmaceuticals
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Amylyx Pharmaceuticals, Inc. has appointed Dan Monahan as Chief Commercial Officer. Mr Monahan brings over 20 years of commercial leadership experience in the biopharmaceutical industry and will lead the Company’s commercialization efforts, particularly in preparation for the potential approval of avexitide, an investigational treatment for post-bariatric hypoglycemia (PBH).
Quick answer
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025). Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Amylyx Pharmaceuticals?
- Amylyx Pharmaceuticals named Dan Monahan Chief Commercial Officer, announced January 6, 2025.
- What did Amylyx Pharmaceuticals announce on January 6, 2025?
- Amylyx Pharmaceuticals, Inc. has appointed Dan Monahan as Chief Commercial Officer. Mr Monahan brings over 20 years of commercial leadership experience in the biopharmaceutical industry and will lead the Company’s commercialization efforts, particularly in preparation for the potential approval of avexitide, an investigational treatment for post-bariatric hypoglycemia (PBH).
- What does Amylyx Pharmaceuticals do?
- Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments.
- Where is Amylyx Pharmaceuticals based?
- Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Harrow (January 7, 2025), Tarsier Pharma (January 7, 2025), Centessa Pharmaceuticals plc (January 8, 2025) and Nimbus Therapeutics (January 9, 2025) also announced leadership changes within 45 days of Amylyx Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Harrow Appoints Amir H. Shojaei as Chief Scientific Officer (January 7, 2025)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
- Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer (January 15, 2025)
- Oragenics Appoints Janet Huffman as Interim Chief Executive Officer (January 17, 2025)
Who to call at Amylyx Pharmaceuticals, and when
A new leader at Amylyx Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Amylyx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amylyx Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amylyx Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amylyx Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Amylyx Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.